{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T10:08:31Z","timestamp":1777802911460,"version":"3.51.4"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2016YFC1306802"],"award-info":[{"award-number":["2016YFC1306802"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2016YFC1306900"],"award-info":[{"award-number":["2016YFC1306900"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["16JC1420500"],"award-info":[{"award-number":["16JC1420500"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81771440"],"award-info":[{"award-number":["81771440"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81361120389"],"award-info":[{"award-number":["81361120389"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.psychres.2019.01.095","type":"journal-article","created":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T11:58:28Z","timestamp":1548849508000},"page":"782-787","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["An investigation of calcium-independent phospholipase A2 (iPLA2) and cytosolic phospholipase A2 (cPLA2) in schizophrenia"],"prefix":"10.1016","volume":"273","author":[{"given":"Chuangye","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuhan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liya","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianqi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changqun","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Qing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaowen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dandan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengkun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaoping","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuanxin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunling","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2090\u20135904","key":"10.1016\/j.psychres.2019.01.095_bib0001","article-title":"Maintenance of synaptic stability requires calcium-independent phospholipase A\u2082 activity","volume":"2012","author":"Allyson","year":"2012","journal-title":"Neural Plast."},{"key":"10.1016\/j.psychres.2019.01.095_bib0002","doi-asserted-by":"crossref","first-page":"18248","DOI":"10.1074\/jbc.M000271200","volume":"275","author":"Atsumi","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"18","key":"10.1016\/j.psychres.2019.01.095_bib0003","doi-asserted-by":"crossref","first-page":"8527","DOI":"10.1073\/pnas.92.18.8527","article-title":"Inhibition of calcium-independent phospholipase A2 prevents arachidonic acid incorporation and phospholipid remodeling in P388D1 macrophages","volume":"92","author":"Balsinde","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.psychres.2019.01.095_bib0004","series-title":"Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation, and Radiation Injury 3","first-page":"99","article-title":"Function of calcium-independent phospholipase A2 in arachidonic acid metabolism in P388D1 macrophages","author":"Balsinde","year":"1997"},{"issue":"6","key":"10.1016\/j.psychres.2019.01.095_bib0005","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s00406-007-0736-0","article-title":"Association between Ban I genotype and increased phospholipase A2 activity in schizophrenia","volume":"257","author":"Barbosa","year":"2007","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"2","key":"10.1016\/j.psychres.2019.01.095_bib0006","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.plefa.2009.05.024","article-title":"Cellular and molecular events mediated by docosahexaenoic acid-derived neuroprotectin D1 signaling in photoreceptor cell survival and brain protection","volume":"81","author":"Bazan","year":"2009","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"issue":"6","key":"10.1016\/j.psychres.2019.01.095_bib0007","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1124\/mol.106.030833","article-title":"Nicotinic acid-induced flushing is mediated by activation of epidermal langerhans cells","volume":"70","author":"Beny\u00f3","year":"2006","journal-title":"Mol. Pharmacol."},{"issue":"2","key":"10.1016\/j.psychres.2019.01.095_bib0008","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2174\/157015911795596595","article-title":"Oxidative stress in schizophrenia","volume":"9","author":"Bo\u0161kovi\u0107","year":"2011","journal-title":"Curr. Neuropharmacol."},{"issue":"2\u20133","key":"10.1016\/j.psychres.2019.01.095_bib0009","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.psychres.2005.10.010","article-title":"Niacin skin flushing in schizophrenic and depressed patients and healthy controls","volume":"143","author":"Bosveld-van Haandel","year":"2006","journal-title":"Psychiatry Res."},{"issue":"19","key":"10.1016\/j.psychres.2019.01.095_bib0010","doi-asserted-by":"crossref","first-page":"7708","DOI":"10.1073\/pnas.87.19.7708","article-title":"Purification of a 110-kilodalton cytosolic phospholipase A2 from the human monocytic cell line U937","volume":"87","author":"Clark","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.psychres.2019.01.095_bib0011","doi-asserted-by":"crossref","first-page":"532","DOI":"10.2174\/092986712798918851","article-title":"n-3 fatty acid-derived lipid mediators in the brain: new weapons against oxidative stress and inflammation","volume":"19","author":"Farooqui","year":"2012","journal-title":"Curr. Med. Chem."},{"issue":"1","key":"10.1016\/j.psychres.2019.01.095_bib0012","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0165-3806(94)90012-4","article-title":"Blockade of long-term depression in neonatal hippocampal slices by a phospholipase A2 inhibitor","volume":"78","author":"Fitzpatrick","year":"1994","journal-title":"Dev. Brain Res."},{"issue":"5548","key":"10.1016\/j.psychres.2019.01.095_bib0013","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1126\/science.294.5548.1871","article-title":"Prostaglandins and leukotrienes: advances in eicosanoid biology","volume":"294","author":"Funk","year":"2001","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.psychres.2019.01.095_bib0014","first-page":"495","article-title":"Increased serum phospholipase A2 activity in schizophrenia: a replication study","volume":"28","author":"Gattaz","year":"1990","journal-title":"Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.psychres.2019.01.095_bib0015","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0006-3223(87)90164-8","article-title":"Increased plasma phospholipase-A2 activity in schizophrenic patients: reduction after neuroleptic therapy","volume":"22","author":"Gattaz","year":"1987","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.psychres.2019.01.095_bib0016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0920-9964(94)00060-L","article-title":"Increased platelet phospholipase A2 activity in schizophrenia","volume":"16","author":"Gattaz","year":"1995","journal-title":"Schizophr. Res."},{"issue":"3","key":"10.1016\/j.psychres.2019.01.095_bib0017","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1006\/scdb.1997.0151","article-title":"Phospholipases A2","volume":"8","author":"Gij\u00f3n","year":"1997","journal-title":"Semin. Cell Dev. Biol."},{"issue":"1\u20132","key":"10.1016\/j.psychres.2019.01.095_bib0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.psychres.2012.09.041","article-title":"Red blood cell polyunsaturated fatty acids measured in red blood cells and schizophrenia: a meta-analysis","volume":"207","author":"Hoen","year":"2013","journal-title":"Psychiatry Res."},{"issue":"3","key":"10.1016\/j.psychres.2019.01.095_bib0019","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0006-3223(99)00010-4","article-title":"Clinical subtyping reveals significant differences in calcium-dependent phospholipase A2 activity in schizophrenia","volume":"46","author":"Hudson","year":"1999","journal-title":"Biol. Psychiatry"},{"issue":"10","key":"10.1016\/j.psychres.2019.01.095_bib0020","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/mp.2015.68","article-title":"Effects of glutamate positive modulators on cognitive deficits in schizophrenia: a systematic review and meta-analysis of double-blind randomized controlled trials","volume":"20","author":"Iwata","year":"2015","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.psychres.2019.01.095_bib0021","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.schres.2013.03.026","article-title":"Antipsychotic drugs decrease iPLA2 gene expression in schizophrenia","volume":"147","author":"Kerr","year":"2013","journal-title":"Schizophr. Res."},{"issue":"4","key":"10.1016\/j.psychres.2019.01.095_bib0022","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jclinepi.2012.09.016","article-title":"Testing a tool for assessing the risk of bias for nonrandomized studies showed moderate reliability and promising validity","volume":"66","author":"Kim","year":"2013","journal-title":"J. Clin. Epidemiol."},{"issue":"5","key":"10.1016\/j.psychres.2019.01.095_bib0023","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.bcp.2005.11.019","article-title":"Niacin induces PPARgamma expression and transcriptional activation in macrophages via HM74 and HM74a-mediated induction of prostaglandin synthesis pathways","volume":"71","author":"Knowles","year":"2006","journal-title":"Biochem. Pharmacol."},{"issue":"6","key":"10.1016\/j.psychres.2019.01.095_bib0024","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1159\/000110430","article-title":"Molecular mechanisms of schizophrenia","volume":"20","author":"Lang","year":"2007","journal-title":"Cell. Physiol. Biochem. Int. J. Exp. Cell. Physiol. Biochem. Pharmacol."},{"issue":"7","key":"10.1016\/j.psychres.2019.01.095_bib0025","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1515\/CCLM.2003.138","article-title":"Fluorometric assays of phospholipase A2 activity with three different substrates in biological samples of patients with schizophrenia","volume":"41","author":"Lasch","year":"2003","journal-title":"Clin. Chem. Lab. Med."},{"issue":"6","key":"10.1016\/j.psychres.2019.01.095_bib0026","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/sj.mp.4001819","article-title":"The role of phospholipases A2 in schizophrenia","volume":"11","author":"Law","year":"2006","journal-title":"Mol. Psychiatry"},{"issue":"4","key":"10.1016\/j.psychres.2019.01.095_bib0027","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.plefa.2003.12.013","article-title":"The investigation of cytosolic phospholipase A2 using ELISA","volume":"70","author":"Macdonald","year":"2004","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"issue":"3","key":"10.1016\/j.psychres.2019.01.095_bib0028","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0022-3565(24)36534-6","article-title":"Nicotine-induced inhibition of neuronal phospholipase A2","volume":"280","author":"Marin","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.psychres.2019.01.095_bib0029","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0920-9964(02)00311-0","article-title":"The niacin skin flush abnormality in schizophrenia: a quantitative dose-response study","volume":"62","author":"Messamore","year":"2003","journal-title":"Schizophr. Res."},{"issue":"1\u20133","key":"10.1016\/j.psychres.2019.01.095_bib0030","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.schres.2010.03.025","article-title":"Niacin sensitivity and the arachidonic acid pathway in schizophrenia","volume":"122","author":"Messamore","year":"2010","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.psychres.2019.01.095_bib0031","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.brainresbull.2008.03.015","article-title":"The high-affinity niacin receptor HM74A is decreased in the anterior cingulate cortex of individuals with schizophrenia","volume":"77","author":"Miller","year":"2008","journal-title":"Brain Res. Bull."},{"issue":"3","key":"10.1016\/j.psychres.2019.01.095_bib0032","first-page":"e123","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"3","author":"Moher","year":"2009","journal-title":"Open Med."},{"issue":"1","key":"10.1016\/j.psychres.2019.01.095_bib0033","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0163-7827(03)00037-7","article-title":"Recent advances in molecular biology and physiology of the prostaglandin E2-biosynthetic pathway","volume":"43","author":"Murakami","year":"2004","journal-title":"Prog. Lipid Res."},{"issue":"46","key":"10.1016\/j.psychres.2019.01.095_bib0034","doi-asserted-by":"crossref","first-page":"33405","DOI":"10.1074\/jbc.M704133200","article-title":"Class A scavenger receptor-mediated macrophage adhesion requires coupling of calcium-independent phospholipase A(2) and 12\/15-lipoxygenase to Rac and Cdc42 activation","volume":"282","author":"Nikolic","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"2\u20133","key":"10.1016\/j.psychres.2019.01.095_bib0035","first-page":"181","article-title":"Absent response to niacin skin patch is specific to schizophrenia and independent of smoking","volume":"152","author":"NikolicLiu","year":"2007","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psychres.2019.01.095_bib0036","series-title":"Meta-analysis of clinical trials","first-page":"397","author":"O'Rourke","year":"2001"},{"issue":"6","key":"10.1016\/j.psychres.2019.01.095_bib0037","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1021\/acschemneuro.5b00073","article-title":"Synthetic and natural inhibitors of phospholipases A2: their importance for understanding and treatment of neurological disorders","volume":"6","author":"Ong","year":"2015","journal-title":"ACS Chem. Neurosci."},{"issue":"12","key":"10.1016\/j.psychres.2019.01.095_bib0038","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1172\/JCI27160","article-title":"Flushing out the role of GPR109A (HM74A) in the clinical efficacy of nicotinic acid","volume":"115","author":"Pike","year":"2005","journal-title":"J. Clin. Investig."},{"issue":"7","key":"10.1016\/j.psychres.2019.01.095_bib0039","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/sj.mp.4001511","article-title":"Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress","volume":"9","author":"Prabakaran","year":"2004","journal-title":"Mol. Psychiatry"},{"issue":"9","key":"10.1016\/j.psychres.2019.01.095_bib0040","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1194\/jlr.R058701","article-title":"Calcium-independent phospholipases A2 and their roles in biological processes and diseases","volume":"56","author":"Ramanadham","year":"2015","journal-title":"J. Lipid Res."},{"issue":"5","key":"10.1016\/j.psychres.2019.01.095_bib0041","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1001\/archpsyc.1997.01830170113015","article-title":"Increased phospholipid breakdown in schizophrenia","volume":"54","author":"Ross","year":"1997","journal-title":"Arch. Gen. Psychiatry"},{"issue":"2","key":"10.1016\/j.psychres.2019.01.095_bib0042","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0006-8993(99)01123-3","article-title":"Differential alteration of phospholipase A2 activities in brain of patients with schizophrenia","volume":"821","author":"Ross","year":"1999","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.psychres.2019.01.095_bib0043","first-page":"45","article-title":"Increased calcium-independent lipoprotein phospholipase A2 but not protein S100 in patients with schizophrenia","volume":"28","author":"\u0160aki\u0107","year":"2016","journal-title":"Psychiatr. Danub."},{"issue":"5","key":"10.1016\/j.psychres.2019.01.095_bib0044","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1089\/jop.1998.14.447","article-title":"Influence of nicotine and cotinine on retinal phospholipase A2 and its significance to macular function","volume":"14","author":"Sastry","year":"1998","journal-title":"J. Ocul. Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.psychres.2019.01.095_bib0045","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.biopsych.2004.11.018","article-title":"Increased calcium-independent phospholipase A2 activity in first but not in multiepisode chronic schizophrenia","volume":"57","author":"Smesny","year":"2005","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.psychres.2019.01.095_bib0046","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.plefa.2007.08.006","article-title":"Endophenotype properties of niacin sensitivity as marker of impaired prostaglandin signalling in schizophrenia","volume":"77","author":"Smesny","year":"2007","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"issue":"4","key":"10.1016\/j.psychres.2019.01.095_bib0047","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.neuroimage.2010.05.009","article-title":"Phospholipase A\u2082 activity is associated with structural brain changes in schizophrenia","volume":"52","author":"Smesny","year":"2010","journal-title":"Neuroimage"},{"issue":"20","key":"10.1016\/j.psychres.2019.01.095_bib0048","doi-asserted-by":"crossref","first-page":"14194","DOI":"10.1074\/jbc.M114.561910","article-title":"Group VIA phospholipase A2 mitigates palmitate-induced \u03b2-cell mitochondrial injury and apoptosis","volume":"289","author":"Song","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.psychres.2019.01.095_bib0049","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1471-4159.2007.04670.x","article-title":"The roles of NADPH oxidase and phospholipases A2 in oxidative and inflammatory responses in neurodegenerative diseases","volume":"103","author":"Sun","year":"2007","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.psychres.2019.01.095_bib0050","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1093\/schbul\/sbx150","article-title":"Identification of the niacin-blunted subgroup of schizophrenia patients from mood disorders and healthy individuals in Chinese population","volume":"44","author":"Sun","year":"2018","journal-title":"Schizophr. Bull."},{"issue":"1","key":"10.1016\/j.psychres.2019.01.095_bib0051","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.bbrc.2006.04.051","article-title":"Enhancement of arachidonic acid signaling pathway by nicotinic acid receptor HM74A","volume":"345","author":"Tang","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.psychres.2019.01.095_bib0052","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0920-9964(02)00281-5","article-title":"Increased phospholipase A2 activity in schizophrenia with absent response to niacin","volume":"61","author":"Tavares","year":"2003","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2019.01.095_bib0053","first-page":"353","article-title":"Methods for the detection of altered \u03b2-adrenergic receptor signaling pathways in hypertrophied hearts","volume":"112","author":"Wolf","year":"2005","journal-title":"Methods Mol. Med."},{"issue":"7","key":"10.1016\/j.psychres.2019.01.095_bib0054","doi-asserted-by":"crossref","first-page":"e1176","DOI":"10.1038\/tp.2017.152","article-title":"Serum fatty acid patterns in patients with schizophrenia: a targeted metabonomics study","volume":"7","author":"Yang","year":"2017","journal-title":"Transl. Psychiatry"},{"issue":"2","key":"10.1016\/j.psychres.2019.01.095_bib0055","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/schbul\/sbv130","article-title":"Prevalence and specificity of the abnormal niacin response: a potential endophenotype marker in schizophrenia","volume":"42","author":"Yao","year":"2016","journal-title":"Schizophr. Bull."}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178118314136?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178118314136?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T20:34:25Z","timestamp":1777494865000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178118314136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":55,"alternative-id":["S0165178118314136"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2019.01.095","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An investigation of calcium-independent phospholipase A2 (iPLA2) and cytosolic phospholipase A2 (cPLA2) in schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2019.01.095","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}